DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY24 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $1.96 to $2.02 for the period, compared to the consensus EPS estimate of $2.01. The company issued revenue guidance of $3.86 billion to $3.90 billion, compared to the consensus revenue estimate of $3.92 billion. DENTSPLY SIRONA also updated its FY 2024 guidance to 1.960-2.020 EPS.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on XRAY. StockNews.com downgraded shares of DENTSPLY SIRONA from a buy rating to a hold rating in a report on Friday, May 3rd. Needham & Company LLC lowered their price target on shares of DENTSPLY SIRONA from $36.00 to $34.00 and set a buy rating for the company in a research report on Wednesday. Piper Sandler reaffirmed a neutral rating and issued a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a report on Friday, May 3rd. Evercore ISI cut their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an outperform rating on the stock in a research note on Tuesday, July 9th. Finally, Robert W. Baird reduced their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating for the company in a report on Monday, July 22nd. Five equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of Moderate Buy and a consensus target price of $33.44.

DENTSPLY SIRONA Stock Down 4.6 %

Shares of NASDAQ:XRAY traded down $1.24 during mid-day trading on Friday, hitting $25.49. 5,126,032 shares of the company traded hands, compared to its average volume of 2,767,748. The firm has a market cap of $5.17 billion, a P/E ratio of -57.93, a PEG ratio of 1.28 and a beta of 1.01. The firm’s 50 day simple moving average is $26.18 and its 200 day simple moving average is $30.08. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.97 and a current ratio of 1.33. DENTSPLY SIRONA has a 52-week low of $23.94 and a 52-week high of $40.92.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period last year, the company posted $0.51 earnings per share. On average, equities analysts anticipate that DENTSPLY SIRONA will post 1.99 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 3,577 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 31st. The stock was acquired at an average cost of $27.95 per share, with a total value of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at $1,631,553.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.52% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.